title: Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis.
authors: Division of HematologyôOncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
authors: Nicole
authors: N
authors: Randall
authors: Elizabeth L
authors: EL
authors: Courville
authors: Linda
authors: L
authors: Baughn
authors: Lawrence
authors: L
authors: Afrin
authors: Celalettin
authors: C
authors: Ustun
mesh_terms: D000814:Aniline Compounds; D000970:Antineoplastic Agents; D001549:Benzamides; D005260:Female; D006223:Hamartoma Syndrome, Multiple / Q000235:genetics*; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000378:metabolism*; D034721:Mastocytosis, Systemic / Q000235:genetics*; D009570:Nitriles; D051059:PTEN Phosphohydrolase / Q000235:genetics*; D010879:Piperazines; D011743:Pyrimidines; D011804:Quinolines
chemical_list: D000814:Aniline Compounds; D000970:Antineoplastic Agents; D001549:Benzamides; D009570:Nitriles; D010879:Piperazines; D011743:Pyrimidines; D011804:Quinolines; D051059:PTEN Phosphohydrolase